Mesoblast Limited is a biotechnology company developing regenerative medicine therapies, focusing on stem cell treatments for inflammatory diseases and immune-related conditions.
Ticker code: ASX:MSB
Sector: Healthcare | Industry: Biotechnology | Website: https://www.mesoblast.com
Market Information
| Market Capitalisation | Enterprise Value | Shares Outstanding | Free Float [%] | Free Float Value |
|---|---|---|---|---|
| $2,959,502,738 | $2,836,347,904 | 1281170048 | 61.49 | $1,819,688,976 |
Balance Sheet & Quality
| Equity | Cash | Debt | Return On Equity (ROE) | EBITDA 24 Margin [%] | Net Debt / Equity [%] | Rule of 40 |
|---|---|---|---|---|---|---|
| $598,306,447 | $161,551,008 | $128,157,000 | -28.5 | -1024.6 | -5.6 | None |
Technicals & Short Data
| 3EMA Status | Volatility [%] | Value Traded Today | Average Daily Liquidity | Short [%] | Days To Cover |
|---|---|---|---|---|---|
| Partial | 5.6 | $11,526,442 | $11,608,540 | 5.94 | 15.1 |
Dividends
| Previous Dividend | Last Dividend | Franking [%] | Ex-Div Date | Gross Yield [%] |
|---|---|---|---|---|
| None | None | None | None | 0.0 |
Price Performance Snapshot
| Last Traded Price | Change [%] | 1 Week [%] | 1 Month [%] | 3 Months [%] | 6 Months [%] | 12 Months [%] |
|---|---|---|---|---|---|---|
| $2.310 | 3.1 | 19.1 | 0.9 | 24.9 | 11.6 | 145.7 |
ASX:MSB Price Chart with Volume and 3EMA
ASX:MSB Short Positions
Click HERE to understand why the above moving averages have been chosen.